Celcuity (CELC) Current Leases (2018 - 2026)
Celcuity's (CELC) quarterly Current Leases came in at $54000.0 in Q4 2025, down 68.6% YoY from $172000.0 in Q4 2024, and down 43.75% on a QoQ basis from $96000.0 in Q3 2025.
Celcuity (CELC) Current Leases (2018 - 2026) Analysis & Trends
Celcuity (CELC) has 8 years of Current Leases data on file, last reported at $54000.0 in Q4 2025.
- Quarterly Current Leases fell 68.6% year-over-year to $54000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $54000.0 (down 68.6% YoY) and the FY2025 annual result came in at $54000.0, down 68.6% from the prior year.
- Current Leases declined to $54000.0 in Q4 2025, from $96000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $194895.0 in Q1 2023 to a low of $5379.0 in Q2 2022.
- A 5-year average of $133890.2 and a median of $173613.0 in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases tumbled 96.5% — and 2023, when it jumped 3457.04%.
- Tracing CELC's Current Leases over 5 years: stood at $189858.0 in 2021, then increased by 1.0% to $191749.0 in 2022, then decreased by 3.55% to $184950.0 in 2023, then slipped by 7.0% to $172000.0 in 2024, then slumped by 68.6% to $54000.0 in 2025.
- The last three Current Leases figures came in at $54000.0 (Q4 2025), $96000.0 (Q3 2025), and $139000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Celcuity | 4.50 Bn | 4.50 Bn | - | 257,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 257,000.00 |
| Dec 31, 2025 | 54,000.00 |
| Sep 30, 2025 | 96,000.00 |
| Jun 30, 2025 | 139,000.00 |
| Mar 31, 2025 | 169,000.00 |
| Dec 31, 2024 | 172,000.00 |
| Sep 30, 2024 | 175,226.00 |
| Jun 30, 2024 | 178,587.00 |
| Mar 31, 2024 | 181,882.00 |
| Dec 31, 2023 | 184,950.00 |
| Sep 30, 2023 | 188,100.00 |
| Jun 30, 2023 | 191,333.00 |
| Mar 31, 2023 | 194,895.00 |
| Dec 31, 2022 | 191,749.00 |
| Sep 30, 2022 | 194,643.00 |
| Jun 30, 2022 | 5,379.00 |
| Mar 31, 2022 | 5,860.00 |
| Dec 31, 2021 | 189,858.00 |
| Sep 30, 2021 | 5,840.00 |
| Jun 30, 2021 | 153,684.00 |